Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Karsten Fjärstedt, Greg Yap, Joshua Salafsky

Premium

Denator said this week that it has named Karsten Fjärstedt vice president for global sales and marketing.

Fjärstedt joins the company from GE Healthcare Life Sciences where he has held senior management positions for the last 10 years.


Biodesy said this week that it has named Greg Yap as CEO and a director. Company founder Joshua Salafsky has been appointed as chief science officer and a director.

Yap joins the company after a stint as GE's first healthcare entrepreneur in residence. Previously he held an executive position at Ventana Medical Systems, overseeing that company's cancer assay portfolio. Prior to that post he was chief operating officer at CELLective Dx and held multiple management roles at Affymetrix, including vice president of DNA Products and vice president of molecular diagnostics.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.